Skip Navigation
What's new What's New       Calendar Calendar  
Help Help    
Home Documents Information
Exchange
Services
Special
Topics
Resources State
Information
Federal Online
Resources
Private Online
Resources

This page contains links to external Web sites.
The Treatment Improvement Exchange has no control over their content or availability.




Performance-Based Monitoring in Narcotic Addiction Treatment

Dorynne Czechowicz, M.D., National Institute on Drug Abuse (NIDA); Laura Graham, M.P.A., Quintiles, Inc.; and Bill Luckey, Ph.D., Research Triangle Institute (RTI)

Narcotic addiction treatment is a vital component of the national effort to reduce opioid and injection drug use and its consequences. The quality and outcomes of narcotic addiction treatment are, therefore, of great importance to the alcohol and other drug (AOD) abuse treatment field. A performance-based measurement system in narcotic addiction treatment programs has the potential to help clinics improve the services they deliver to their patients.

The National Institute on Drug Abuse/National Institutes of Health (NIDA/NIH) is funding a study called the Methadone Treatment Quality Assurance System (MTQAS) that is designed to determine the feasibility and usefulness of a performance-based feedback system for narcotic addiction treatment programs. The study is being conducted by the Research Triangle Institute (RTI) in collaboration with the Center for Substance Abuse Treatment (CSAT) and the National Association of State Alcohol and Drug Abuse Directors (NASADAD).

Focus on Quality

Treatment program staff are concerned with quality improvement. In addition, managed care entities and payers are increasingly interested in managing costs and quality for the purpose of achieving optimal value for the dollars spent and services provided. Though many measurement, data management, and reporting methods and tools were developed for the primary health care field, they are just now being used by the substance abuse treatment field.

In assessing quality, one challenge has been how to define and identify appropriate indicators of quality improvement. Performance indicators are most useful if they are defined and measurable, can be tracked over time, and accurately reflect the treatment process.

MTQAS is designed as an outcomes-based monitoring system that tracks program performance over time based on patient outcomes. Phase I of MTQAS, which ended in July 1995, focused on designing the system and testing a prototype for a limited time in a relatively small number of clinics. Phase II is a full-scale assessment of the feedback system in which many narcotic addiction treatment clinics in seven States participated. Data collection began in 1996 and continued through 1998. Study staff are analyzing both quantitative and qualitative data to understand what is required to implement and operate such a system and to determine how programs and States use the information.

Phase I: Defining Indicators

Phase I of MTQAS answered several key questions:

  • Which performance indicators, including treatment outcomes, can usefully serve as the basis for a performance measurement system? This system must be capable of comparing client outcomes fairly across clinics by adjusting for a program's "case-mix" (that is, by separating the contribution of client characteristics from the program's performance).

  • How might performance feedback be structured so that it provides the greatest assistance to clinics? What operational problems might arise if such a system were implemented?

    In devising a strategy to answer these questions, MTQAS staff consulted an advisory panel of providers, researchers, quality assurance experts, representatives from national health professional organizations, and Federal agency representatives. Staff then developed a client-level data collection instrument (Client Assessment Profile or CAP) that was field tested in Phase I. The first part of the field test was conducted in five narcotic addiction treatment clinics. Based on inter-rater reliability tests and clinician ratings, the items in the CAP proved to have both high validity and reliability.

    The second part of the field test involved a controlled 6-month test of the performance reporting system in 25 narcotic addiction treatment clinics in 16 States and the District of Columbia. Program staff collected data on approximately 1,200 patients and provided one feedback report to each participating clinic. The feedback report contained descriptive data about each program's patients and, based on case-mixed data, provided quintile ranks for each outcome. MTQAS staff met with program directors to obtain feedback about their experience participating in MTQAS and about the usefulness of the information provided to them.

    Phase I Findings

    Phase I resulted in good information about which outcomes form the basis for a performance monitoring system and which patient-level information is necessary to case-mix the data. Additionally, the Phase I program directors had a significant impact on the structure of Phase II, particularly the operational issues associated with MTQAS and the structure and format of the performance feedback.

    Phase II: Testing the System

    Phase II was a full-scale assessment of the MTQAS system. Phase II's goals were to:

  • Determine whether a performance-based system can be implemented in narcotic addiction treatment clinics on an ongoing basis and identify any operational problems with such a system.

  • Assess whether performance feedback — either alone or in combination with technical assistance — can be used to guide changes in clinic processes or procedures that will enhance the quality of care provided.

  • Assess the efficacy of the MTQAS system for improving selected in-treatment outcomes (that is, outcomes that should be rapidly influenced by relatively minor changes in clinical protocols, such as dosing policies).

    MTQAS Phase II was innovative for several reasons. First, Phase II was implemented in 7 States and approximately 80 clinics, over a third of which were private. Nearly 80 percent of clinics in the States participated to some degree. Second, the study involved a partnership among providers, the States, and the research community. Clinic staff collected intake and quarterly follow-up information on all patients in narcotic addiction treatment over a period of 18 months. Each State processed the data as it was received from its clinics, and sent a data file to RTI for analysis and production of the Quarterly Performance Feedback Reports. Finally, CSAT provided technical assistance to a sample of the participating clinics whose outcomes were below expectations.

    The MTQAS study design allowed for comparisons across clinics, across funding and regulatory environments, and across time. Seven States participated: Arizona, Colorado, Georgia, Massachusetts, North Carolina, Pennsylvania, and Washington. MTQAS was implemented statewide in each, in both public and private clinics. Pennsylvania had some difficulty implementing this approach because of changes in the public health care system, and eventually discontinued data collection. Reassessments were ongoing, with quarterly performance feedback reports provided to the clinics. Ten clinics also received technical assistance (TA) through CSAT to translate the MTQAS feedback into action. A standardized, on-site assessment was conducted at clinics selected for TA by an experienced narcotic addiction treatment provider to develop the TA plan. The TA delivery occurred in early 1998.

    The MTQAS study fostered discussion among the narcotic addiction clinics, State offices, CSAT, NIDA, and the research community. Such communication is important to determine how the performance-based outcome information can best be used for improving the quality of narcotic addiction treatment.

    In addition to producing the feedback reports, RTI staff also assessed the implementation of MTQAS through quarterly calls to State staff. RTI staff were interested in learning what challenges were encountered and how they were being addressed during the MTQAS implementation. Study staff are to visit each of the States at the conclusion of the study to meet with providers and State staff. These meetings are designed to obtain a better understanding of what it took to implement MTQAS, the usefulness of the feedback reports, including both the value and limitations of the information, and how the system might be improved.

    Description of MTQAS Assessments

    The performance feedback reports were based on patient-level data collected by clinic staff. Most items necessary for the performance feedback reports were items that a clinician would ask as part of a routine assessment. The experience in Phase I demonstrated that if MTQAS were to be successful, the system needed to be embedded within clinic operations. Clinics sent their data to their State office, which acted as a clearinghouse for the data. In each State office, a contact person was responsible for shipping the data to RTI on a monthly basis. The MTQAS assessment schedule for each patient included the following:

  • An initial assessment. This contained the key pieces of information to provide baseline measures for outcomes, as well as other patient characteristics that were used to adjust for differences in the types of patients served when making comparisons across participating clinics (that is, the case-mix adjustment). MTQAS staff selected these items on the basis of previous research, including Phase I of MTQAS. The initial assessment, completed at admission, took no more than 10 minutes.

  • Periodic reassessments. These included items based on interviews, as well as items recorded from the patient record. These follow-up items were required for the outcome analyses and included in-treatment behaviors, such as drug use, injecting behavior, arrests, and urinalysis results. These measures were commonly applied to drug treatment outcomes. The measures were also useful for a counselor to ask and observe during regular treatment plan reviews. Actual timing of the periodic reassessments was determined for each patient according to the date of admission. Reassessments were conducted on a quarterly basis for patients who had been in treatment less than 1 year ("shorter term") and biannually for patients who had been in treatment more than 1 year ("longer term").

    The periodic reassessments, including completing the record data, took approximately 10 minutes per patient.

  • Client profile. Five items on client demographics were collected one time only from patients already in treatment when the MTQAS data collection began. These five items were necessary for the minimal case-mix adjustment methods.

  • Client discharge. The discharge information collected included the date and reason for discharge. This information, extracted from the patient record, was completed when a patient left a clinic.

    The Case-Mix Adjustment Process

    One important reason that outcomes may differ across clinics is that clinics serve different types of patients. Case-mix adjustment is a way of leveling the playing field when comparing outcomes across clinics that have different patient populations.

    Case-mix adjustment is used to look at patient outcomes in a wide range of service settings: hospitals, nursing homes, home health agencies, ambulatory care settings, and mental health clinics. In MTQAS, this process was used to adjust for different patient populations when comparing or ranking clinics according to their patients' outcomes.

    Case-mix adjustment involves a statistical analysis in which patient characteristics and baseline behaviors are used to predict patient outcomes. For each outcome, a different statistical model is used. For example, one of the outcomes is "no arrests." How well each clinic does on this outcome is estimated, while adjusting for a number of factors that may affect patients' arrest rates. These factors include patients' age, gender, race, current criminal justice status, and arrest

    history.

    MTQAS Indicators/Outcomes

    MTQAS used a variety of outcomes as part of the performance reporting system. An important part of the study's development was determining which outcomes would be most appropriate to include in a performance feedback system. The MTQAS outcomes included self-reported drug-using behaviors and results from urine tests, as well as social functioning, physical and mental health, utilization of medical services, the patient's satisfaction with services, and retention in treatment. MTQAS staff selected these outcomes on the basis of MTQAS Phase I results, discussions with the participating State staff and advisory panel members, and a review of pertinent literature. Indicators were selected for the core MTQAS data set. In addition to this core set of outcomes, many States have opted to add other items to their data set. These include HIV-risk behaviors, social support, and the use of other drugs, such as methamphetamine and alcohol.

    Application of MTQAS to Other Treatment Modalities

    Although MTQAS has been developed for and is being tested in narcotic addiction treatment clinics, many of this system's attributes make it applicable to other treatment modalities. This new system provides data on measurable outcomes, tracks performance over time, and uses indicators related to the treatment process. Furthermore, some of the outcomes are associated with changes in costs and may be useful in a cost-offset model.

    The indicators used in MTQAS are likely to be valuable both internally to clinic staff and externally to payers and patients. MTQAS will assist the treatment field in determining how best to implement a performance-based system and how the feedback may be used to implement changes in clinic practices.

    Previous PageNext Page

    Table of Contents

     



    Last Updated